To our best knowledge, many studies verified the roles of PCSK9 in the pathogenesis of hypercholesterolemia and atherosclerosis and several PCSK9-based agents have been available, which then increased the level of LDL-R on the hepatocyte surface. The gene discussed is PCSK9; the disease is atherosclerosis.